Predictive risk factors for coronary artery abnormalities in Kawasaki disease

被引:72
|
作者
Kim, TaeYeun
Choi, WookSun
Woo, Chan-Wook
Choi, ByungMin
Lee, JungHwa
Lee, KwangChul
Son, ChangSung
Lee, JooWon
机构
[1] Korea Univ, Med Ctr, Dept Pediat, Ansan, Kyungki, South Korea
[2] Korea Univ, Coll Med, Dept Pediat, Seoul 136701, South Korea
关键词
Kawasaki disease; coronary abnormality; risk factor; IVGG-non-responsiveness;
D O I
10.1007/s00431-006-0251-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Clinical characteristics to predict the development of coronary artery abnormalities (CAA) in Kawasaki disease (KD) were assessed by reviewing medical records of patients diagnosed with KD at Korea University Medical Center from March 2001 to February 2005. Of the 285 patients diagnosed with KD, 19 developed CAA (6.7%). Compared with the CAA(-) group, the CAA(+) group had a longer duration of fever after intravenous gamma-globulin (IVGG) injection (2.4 +/- 2.9 vs. 1.5 +/- 1.2 days, p=0.008) and higher C-reactive protein (CRP)(12.3 +/- 7.8 vs. 8.7 +/- 7.1 mg/dL p=0.038). In particular, the CAA(+) group tended to have more than 7 days of fever before IVGG and more than 3 days of fever after IVGG (26.3 vs. 5.3%, p < 0.001; 26.3 vs. 6.4%, p=0.002). When the IVGG responsiveness was defined by the presence of defervescence within 3 days after IVGG, IVGG-non-responders showed a higher incidence of CAA (22.7 vs. 5.3%, p=0.002). Non-responders had a longer duration of fever after IVGG (5.5 +/- 1.9 vs. 1.2 +/- 0.6 days, p < 0.001) and a significantly increased CRP, AST, ALT and total bilirubin. Multivariate regression analysis for CAA showed that the only factor significantly associated with the development of CAA was total fever that lasted for longer than 8 days (OR=4.052, 95% CI=1.151-14.263,p=0.0293). Conclusively, the most important predictor of CAA in KD is total duration of fever longer than 8 days. Early identification of IVGG non-responders and active therapeutic intervention for fever in KD cases might decrease the incidence of CAA.
引用
收藏
页码:421 / 425
页数:5
相关论文
共 50 条
  • [21] Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
    Bal, Aswine K.
    Prasad, Deepa
    Pamintuan, Maria Angela Umali
    Mammen-Prasad, Elizabeth
    Petrova, Anna
    PEDIATRICS AND NEONATOLOGY, 2014, 55 (05): : 387 - 392
  • [22] Risk of coronary artery involvement in Kawasaki disease
    Soriano-Ramos, Maria
    Martinez-del Val, Elena
    Negreira Cepeda, Sagrario
    Gonzalez-Tome, Maria I.
    Cedena Romero, Pilar
    Fernandez-Cooke, Elisa
    Albert de la Torre, Leticia
    Blazquez-Gamero, Daniel
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2016, 114 (02): : 107 - 113
  • [23] Coronary artery abnormalities in Kawasaki disease according to patient age
    Esmeralda Nuñez
    Patricia Martínez
    Victorio Cuenca
    Francisco Jesus García
    David Moreno
    Antonio Urda
    Pediatric Rheumatology, 9 (Suppl 1)
  • [24] Kawasaki syndrome and risk factors for coronary artery abnormalities - United States, 1994-2003
    Belay, ED
    Maddox, RA
    Holman, RC
    Curns, AT
    Ballah, K
    Schonberger, LB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) : 245 - 249
  • [25] Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms
    Caballero-Mora, F. J.
    Alonso-Martin, B.
    Tamariz-Martel-Moreno, A.
    Cano-Fernandez, J.
    Sanchez-Bayle, M.
    ANALES DE PEDIATRIA, 2011, 74 (04): : 232 - 238
  • [26] Risk Factors Of Persistent Coronary Artery Dilatation In Taiwanese Children With Kawasaki Disease
    Liu, Ming-Yu
    Liu, Hsin-Min
    Lin, Ming-Tai
    Chen, Chun-An
    Chiu, Shuenn-Nan
    Lu, Chun-Wei
    Wang, Jou-Kou
    Wu, Mei-Hwan
    CIRCULATION, 2015, 131
  • [27] Elevated Soluble Interleukin 2 Is A Risk Of Treatment Resistance And Coronary Artery Abnormalities In Kawasaki Disease
    Takatsuki, Shinichi
    Takebe, Junko
    Naoi, Kazuyuki
    Ikahara, Satoshi
    Nakayama, Tomotaka
    Matsuura, Hiroyuki
    Morita, Toshisuke
    Saji, Tsutomu
    CIRCULATION, 2015, 131
  • [28] Elevated Soluble Interleukin 2 Is A Risk Of Treatment Resistance And Coronary Artery Abnormalities In Kawasaki Disease
    Takatsuki, Shinichi
    Takebe, Junko
    Naoi, Kazuyuki
    Ikahara, Satoshi
    Nakayama, Tomotaka
    Matsuura, Hiroyuki
    Morita, Toshisuke
    Saji, Tsutomu
    CIRCULATION, 2015, 131
  • [29] Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period
    Georgia Giannouli
    Chryssa Tzoumaka-Bakoula
    Ioannis Kopsidas
    Paraskevi Papadogeorgou
    George P. Chrousos
    Athanasios Michos
    Pediatric Cardiology, 2013, 34 : 1476 - 1481
  • [30] Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period
    Giannouli, Georgia
    Tzoumaka-Bakoula, Chryssa
    Kopsidas, Ioannis
    Papadogeorgou, Paraskevi
    Chrousos, George P.
    Michos, Athanasios
    PEDIATRIC CARDIOLOGY, 2013, 34 (06) : 1476 - 1481